Churchill China trading stabilises as cash rises to £8.8 million
Churchill China’s sales remained broadly stable in the first half, while cash rose to £8.8 million and factory performance improved.
This article covers information on Churchill China PLC.
LON:CHHA steadier first half after a difficult 2025
Churchill China PLC has reported a more stable trading performance for the six months ended 30 June 2026, following the market declines experienced during 2025.
The hospitality ceramics manufacturer generated external sales of £37.4 million, compared with £38.5 million in the first half of 2025. That is a £1.1 million reduction, but management described the result as resilient given subdued demand across several hospitality markets.
More encouragingly, cash balances increased significantly, factory performance improved and the company’s capital investment programme began delivering measurable productivity and waste-reduction benefits.
The update does not signal a return to strong growth. Sales visibility remains limited, cost pressures have not disappeared and the final quarter will be important. Even so, Churchill China appears to have moved from deterioration towards greater stability.
The full regulatory wording is available in the original company announcement.
Churchill China’s key first-half figures
| Metric | H1 2026 | H1 2025 | Change |
|---|---|---|---|
| External sales | £37.4 million | £38.5 million | Down £1.1 million |
| Cash balance at 30 June | £8.8 million | £5.6 million | Up £3.2 million |
Churchill China did not disclose first-half profit, margins, order intake or earnings guidance in this trading update. Those figures should become clearer when the company publishes its interim results in early September 2026.
Sales are lower, but trading has stabilised
The headline sales figure is not positive in isolation. External sales declined from £38.5 million to £37.4 million, while hospitality demand remained subdued in a number of markets.
However, the direction of travel matters. Churchill China said sales were broadly in line with the prior year and with the board’s expectations. This follows a difficult market environment in 2025, so stabilisation represents an improvement from the previous pattern of market decline.
Investors can review my earlier coverage of Churchill China’s 2025 results for context on the company’s position entering the current financial year.
Management also said sales in its hospitality markets were broadly flat year on year. The company’s added-value hospitality ranges, including pressure cast products, showed encouraging stability.
Pressure casting is a manufacturing technique used to produce ceramic items efficiently and consistently. These products are important because Churchill China presents them as part of its differentiated, added-value offering rather than relying purely on volume.
The company believes its success in securing new business reflects continued market share gains. That is management’s assessment rather than a separately quantified figure, as the amount of market share gained was not disclosed.
Cash generation is the clearest positive
The strongest number in the announcement is the £8.8 million cash balance at 30 June 2026, up from £5.6 million one year earlier.
That £3.2 million improvement provides evidence that Churchill China’s operational efficiency and working capital discipline are producing tangible financial results. Working capital refers to money tied up in day-to-day operations, including stock, customer payments and amounts owed to suppliers.
Strong cash generation is particularly useful when demand is subdued. It gives Churchill China greater flexibility to continue investing in its manufacturing operations without the update indicating increased balance-sheet strain.
However, the announcement disclosed a cash balance rather than net cash, and did not provide details of debt or lease liabilities. Investors will need to wait for the interim accounts for a complete balance-sheet picture.
Factory improvements are beginning to show results
Churchill China reported improved factory performance and better manufacturing yields during the first half. Manufacturing yield measures the proportion of production that becomes saleable output rather than waste or defective stock.
Higher yields can support profitability by reducing wasted materials, energy and labour. The company said these improvements had mitigated some, but not all, of the cost pressures it faces.
Distribution costs were highlighted as a particular pressure. No figure was provided for the size of those additional costs, so it is not yet possible to judge whether factory savings will be enough to protect first-half margins.
The previously announced capital investment programme is continuing to progress, with spending focused on:
- Productivity
- Automation
- Efficiency improvements
Early results from completed projects are described as measurable. In particular, a new flat plate making machine is delivering benefits in productivity and waste reduction.
This is a useful operational signal. Capital expenditure only creates shareholder value when the resulting savings or additional output justify the cost. The RNS suggests the programme is moving in the right direction, although the investment amount and expected financial return were not disclosed.
Energy hedging offers some protection
Ceramics manufacturing is energy intensive, making energy prices an important cost consideration.
Churchill China said its energy requirements are significantly hedged for the year. Hedging means agreeing prices or using contracts in advance to reduce exposure to future price movements.
As a result, management expects limited exposure to short-term fluctuations in energy prices during 2026. This should improve cost visibility, although it does not remove other pressures, including distribution expenses.
The update did not disclose the proportion of energy requirements hedged or the prices secured.
The main risks have not disappeared
Despite the improved stability, this is not a risk-free update.
Sales visibility remains limited, meaning management has restricted certainty over future customer demand. The board also highlighted the significance of the final quarter, suggesting full-year performance remains dependent on trading later in 2026.
Macro-economic conditions are described as difficult to predict. Weak hospitality investment could continue to affect customer demand, even if Churchill China gains business from competitors.
The ongoing situation in the Middle East was also identified as a risk to performance. The company did not quantify its exposure or explain the specific potential impact, so investors should not assume a particular financial outcome.
Finally, improved factory yields have only offset some cost pressure. If distribution expenses remain elevated while sales are flat or lower, profitability could still come under pressure.
What investors should watch in September
Churchill China’s interim results, expected in early September 2026, should provide the financial detail missing from this short trading update.
The main points to watch will be:
- Profit and margins - to see whether efficiency gains are offsetting distribution and other costs.
- Cash conversion - to understand how the cash balance increased and whether the improvement is sustainable.
- Capital expenditure - including how much has been invested and the expected payback from automation projects.
- Order visibility - particularly ahead of the important final quarter.
- Market share progress - including any evidence supporting management’s belief that Churchill China is strengthening its competitive position.
For now, the investment case has become steadier rather than transformed. Sales remain slightly below the prior year and demand is subdued, but stronger cash, improving factory performance and early benefits from investment provide credible positives.
The September results will show whether that operational progress is also reaching the profit line.
Related
Keep reading
Investing
AstraZeneca’s Enhertu delivers Phase III lung cancer PFS win
Enhertu delayed disease progression versus standard care in a Phase III lung cancer trial, supporting its potential move into first-line treatment.
JoshuaAugust 17, 2026
Investing
Optima Health FY26 results: growth beats expectations as PAM integration begins
Optima Health beat adjusted EBITDA expectations in FY26, while the £100 million PAM acquisition reshaped its growth prospects and balance sheet.
JoshuaAugust 17, 2026
Investing
Nostrum Oil & Gas Agrees $304.6 Million Kazakhstan Sale Ahead of Wind-Down
Nostrum plans to sell its Kazakhstan operations, repay secured notes in full and begin an orderly wind-down after completion.
JoshuaAugust 17, 2026
Tagged
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.